Spark Investment Management LLC Avrobio, Inc. Transaction History

Spark Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$10.08 - $27.21 $367,748 - $992,702	-36,483 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$13.05 - $21.88 $476,103 - $798,248	36,483 New	36,483 $734,000
Q3 2019 Nov 12, 2019	SELL	$14.12 - $23.44 $263,253 - $437,015	-18,644 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$13.21 - $27.29 $255,692 - $528,225	-19,356 Reduced 50.94%	18,644 $303,000
Q1 2019 May 07, 2019	BUY	$12.46 - $22.05 $225,526 - $399,105	18,100 Added 90.95%	38,000 $837,000
Q4 2018 Feb 12, 2019	BUY	$15.43 - $32.7 $155,843 - $330,270	10,100 Added 103.06%	19,900 $331,000
Q3 2018 Nov 13, 2018	BUY	$26.95 - $52.7 $264,110 - $516,460	9,800 New	9,800 $508,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.